Proteases are enzymes that cut other proteins by breaking the peptide bonds holding amino acid chains together. They fall into four major classes based on the chemistry at their active site, and they touch virtually every process in a living cell, from recycling worn-out proteins and triggering blood clotting to enabling virus replication and dismantling a cell during programmed death.1PubMed Central. Cysteine Proteases: Modes of Activation and Future Prospects as Pharmacological Targets Far from being mere demolition enzymes, proteases act as precision switches that cells use to control signaling, development, and defense.
The Four Major Classes
Proteases are grouped by the amino acid or metal ion that does the actual chemistry at the catalytic site. The four classes are serine proteases, cysteine proteases, aspartic proteases, and metalloproteases.1PubMed Central. Cysteine Proteases: Modes of Activation and Future Prospects as Pharmacological Targets Each class uses a fundamentally different chemical strategy to achieve the same outcome: splitting a peptide bond. Some researchers also recognize threonine proteases (the proteasome’s active sites use a threonine residue) and glutamic proteases, but the four-class framework covers the vast majority of known enzymes.
What matters practically is that these classes are not interchangeable. A drug designed to block a serine protease will do nothing to a metalloprotease, because the two active sites look and behave differently. That class-specific chemistry is what makes proteases both biologically versatile and therapeutically targetable.
How Serine Proteases Cut Proteins
Serine proteases are the most widespread class in nature. Their defining feature is a catalytic triad: three amino acid residues, typically serine, histidine, and aspartate, working together to activate the serine’s hydroxyl group so it can attack the target peptide bond.2PubMed Central. Unconventional serine proteases: variations on the catalytic Ser/His/Asp triad configuration The histidine pulls a hydrogen away from the serine, making the serine oxygen a powerful nucleophile. The aspartate, in turn, stabilizes the histidine during this handoff. Recent NMR work on the NS3 protease from dengue virus showed that the hydrogen bond between histidine and aspartate in the triad is unusually short and strong, providing direct physical evidence for a bonding arrangement that theorists had debated for years.3PubMed Central. Direct evidence of a low barrier hydrogen bond in the catalytic triad of a Serine protease
Although the classic serine-histidine-aspartate arrangement dominates, variations on this triad exist. Some serine proteases substitute different residues while still relying on a serine for the actual bond-cutting step.2PubMed Central. Unconventional serine proteases: variations on the catalytic Ser/His/Asp triad configuration Digestive enzymes like trypsin and chymotrypsin belong to this class, as do the clotting factors in blood and many immune-system proteases.
Cysteine and Aspartic Proteases
Cysteine proteases operate on a broadly similar principle to serine proteases, but the attacking group is a sulfur-containing thiol on a cysteine residue rather than an oxygen-containing hydroxyl on a serine. In the best-studied member, papain, the cysteine exists as a thiolate-imidazolium ion pair with a nearby histidine, priming it for attack. Not every cysteine protease uses that exact arrangement, though. Work on picornain 3C, a viral cysteine protease, showed that its active-site cysteine is an ordinary thiol, with the neighboring histidine acting as a general base catalyst rather than forming an ion pair.4PubMed. Thiolate-imidazolium ion pair is not an obligatory catalytic entity of cysteine peptidases: the active site of picornain 3C This means the cysteine protease family is mechanistically more diverse than textbooks sometimes suggest.
Aspartic proteases take a different approach entirely. They use two aspartate residues and a water molecule. The two aspartates activate the water, which then attacks the peptide bond. No covalent intermediate forms between the enzyme and the substrate, unlike in serine or cysteine proteases. HIV protease is a well-known aspartic protease: it functions as a dimer, with each half contributing one of the two essential aspartate residues.5PubMed Central. Viral proteases as therapeutic targets
Metalloproteases and Their Zinc-Dependent Mechanism
Metalloproteases require a metal ion, most commonly zinc, at the active site. The zinc coordinates a water molecule and positions it for attack on the target peptide bond. Detailed computational studies of matrix metalloproteinase-1 (MMP-1), which breaks down collagen, have mapped out the steps. First, a conserved glutamate residue acts as a base and ultimately generates a hydroxide ion from the zinc-bound water. That hydroxide then attacks the carbon of the scissile peptide bond in what the researchers identified as the rate-limiting step, forming a tetrahedral intermediate before the bond fully breaks.6The Journal of Physical Chemistry B. Catalytic Mechanism of Collagen Hydrolysis by Zinc(II)-Dependent Matrix Metalloproteinase‑1
This zinc-water-glutamate machinery is shared across the MMP family, which has more than 20 members in humans. It also extends to other metalloprotease families like the ADAMs (A Disintegrin and Metalloproteases), which clip proteins off cell surfaces, a process called ectodomain shedding.7PubMed. Ectodomain shedding by ADAM proteases as a central regulator in kidney physiology and disease
Intracellular Protein Turnover
Cells constantly break down their own proteins, either because those proteins are damaged, no longer needed, or misfolded. Two major systems handle this work, and both depend on proteases.
The 26S proteasome is a large barrel-shaped complex in the cytoplasm. Proteins tagged with a small protein called ubiquitin are recognized by the proteasome, unfolded by energy-consuming motors, and threaded into the barrel’s interior, where threonine protease active sites chop them into short peptide fragments. Structural studies have illuminated how the proteasome recognizes ubiquitin-tagged substrates, strips off the ubiquitin tags, and uses ATP to unfold and translocate the doomed protein.8PubMed Central. Structure and Function of the 26S Proteasome More recent work has detailed the conformational changes the proteasome undergoes during these steps and how small molecules can modulate its activity, which matters for cancer drugs like bortezomib that deliberately jam the proteasome in tumor cells.9PubMed Central. Structural mechanism of 26S proteasome regulation and its pharmacological modulation
The second system is the lysosome, a membrane-bound compartment filled with acid and proteases called cathepsins. Cathepsins are the workhorses of lysosomal degradation, handling everything from recycling internalized cell-surface receptors to breaking down pathogens engulfed by immune cells.10PubMed Central. The Ins and Outs of Cathepsins: Physiological Function and Role in Disease Management Most cathepsin activity occurs in compartments with a pH between about 4.5 and 6, though some active cathepsins have been found in organelles with higher pH, suggesting their reach extends beyond the most acidic vesicles.11Cell Chemical Biology. Bifunctional Probes of Cathepsin Protease Activity and pH Reveal Alterations in Endolysosomal pH during Bacterial Infection
Zymogens and the Problem of Self-Destruction
A protease that is always active is dangerous. It could chew up the cell that made it. Cells solve this by producing many proteases as inactive precursors called zymogens, which only become active when a specific signal triggers removal of an inhibitory segment. Blood clotting is the textbook example: the coagulation cascade is a chain of serine proteases, each one activating the next by clipping its zymogen form via limited proteolysis.12PubMed Central. How it all starts: Initiation of the clotting cascade This cascade design amplifies a tiny initial signal into a massive, rapid response at a wound site while keeping the proteases inert everywhere else in the bloodstream.
Cells also deploy dedicated protease inhibitors as a second layer of safety. Serpins are a major family of inhibitors that target serine proteases through an unusual mechanism: a serpin acts as a trap that the protease bites into, then the serpin dramatically refolds, yanking the protease into a distorted, inactivated state.13PubMed. Divining the serpin inhibition mechanism: a suicide substrate ‘springe’? Different serpins have different reactive-site loops that determine which protease they trap. Some, like endopin 2, can even cross class boundaries and inhibit both serine and cysteine proteases.14PubMed. Novel secretory vesicle serpins, endopin 1 and endopin 2: endogenous protease inhibitors with distinct target protease specificities
Caspases and Programmed Cell Death
When a cell receives signals telling it to die, whether because it is damaged, infected, or simply surplus during development, a family of cysteine proteases called caspases orchestrates the demolition. Caspases exist as inactive zymogens and undergo a cascade of activation at the onset of apoptosis.15PubMed Central. Caspase activation, inhibition, and reactivation: a mechanistic view Initiator caspases are activated first, often by assembling into large multi-protein platforms. They then cleave and activate downstream executioner caspases, which proceed to dismantle the cell from within by cutting structural proteins, DNA-repair enzymes, and other critical components.16PubMed. Caspase-activation pathways in apoptosis and immunity The result is an orderly death: the cell shrinks, its DNA is fragmented, and it is packaged into neat parcels that neighboring cells and immune cells can clean up without triggering inflammation.
Extracellular Matrix Remodeling and Cancer
Outside the cell, proteases reshape the structural scaffolding that holds tissues together. Matrix metalloproteinases (MMPs) are zinc-dependent enzymes that degrade components of the extracellular matrix (ECM), including collagen, elastin, and fibronectin. This remodeling is essential during normal development, wound healing, and tissue repair.17PubMed Central. Insights Into the Role of Matrix Metalloproteinases in Cancer and its Various Therapeutic Aspects: A Review
Cancer cells exploit this machinery. For a tumor cell to metastasize, it must break through tissue barriers, invade blood vessels, and establish itself at a distant site. MMPs degrade the ECM and blood vessel walls to open pathways for migrating tumor cells. Beyond simple demolition, MMPs also process growth factors, chemokines, and adhesion proteins, effectively reshaping the cellular environment to support tumor growth and spread.18PubMed. Matrix metalloproteinases participation in the metastatic process and their diagnostic and therapeutic applications in cancer Early clinical trials of broad-spectrum MMP inhibitors were disappointing, partly because blocking all MMPs also interfered with protective anti-tumor roles that some family members play. The field has since shifted toward more selective targeting.
Proteases in Alzheimer’s Disease
The amyloid plaques characteristic of Alzheimer’s disease are built from a small peptide called amyloid-beta, which is carved out of a larger precursor protein (APP) by two proteases acting in sequence. Beta-secretase, identified as a transmembrane aspartic protease called BACE, makes the first cut.19PubMed. Beta-secretase cleavage of Alzheimer’s amyloid precursor protein by the transmembrane aspartic protease BACE Gamma-secretase, an aspartic protease complex embedded in the membrane with the presenilin subunit as its catalytic core, makes the second cut and releases the amyloid-beta fragment.20PubMed Central. Structure and mechanism of the γ-secretase intramembrane protease complex
An alternative route exists: alpha-secretase cleaves APP within the amyloid-beta sequence, preventing amyloid-beta from forming at all.21PubMed Central. Amyloid-β production via cleavage of amyloid-β protein precursor is modulated by cell density The balance between these competing protease pathways determines how much amyloid-beta a cell produces. Gamma-secretase is particularly interesting because it cuts proteins inside the lipid bilayer of the membrane, an unusual feat for an enzyme since the membrane interior is oily and water-poor. Biochemical work has shown that gamma-secretase performs two types of cleavage on a single substrate: an initial endopeptidase-like cut followed by processive trimming, generating peptides of different lengths.22PubMed. Molecular mechanism of intramembrane proteolysis by γ-secretase The longer forms, especially the 42-amino-acid version, are the most prone to aggregation and plaque formation.
Viral Proteases as Drug Targets
Many viruses encode their own proteases, which are essential for slicing viral polyproteins into functional pieces after translation. Without these proteases, the virus cannot mature or become infectious. This makes viral proteases attractive drug targets: block the protease and you halt the virus’s life cycle.5PubMed Central. Viral proteases as therapeutic targets
HIV protease, a dimeric aspartic protease, was one of the first viral proteases successfully targeted by drugs. The development of saquinavir in the 1990s opened the door to protease-inhibitor therapy for chronic viral infections.5PubMed Central. Viral proteases as therapeutic targets The SARS-CoV-2 pandemic brought the concept to wider public awareness. The main protease of SARS-CoV-2 (Mpro) is responsible for cleaving at eleven positions along the viral polyproteins, and crystallographic studies have mapped how each of those cleavage sites fits into the enzyme’s active site, providing blueprints for drugs like nirmatrelvir (the active ingredient in Paxlovid).23PubMed Central. X-ray crystallographic characterization of the SARS-CoV-2 main protease polyprotein cleavage sites essential for viral processing and maturation The chemical logic differs between these viruses. HIV protease uses the two-aspartate water-activation mechanism, while the SARS-CoV-2 main protease is a cysteine protease. Nonetheless, the therapeutic strategy is the same: fit a small molecule into the active site and jam it.24The FASEB Journal. Repurposing SARS‐CoV‐2 Main Protease Inhibitors for HIV‐1 Protease Inhibition
Proteases in Receptor Signaling
Some cell-surface receptors are activated not by a traditional ligand docking onto them from the outside but by a protease cutting the receptor’s own extracellular portion. Protease-activated receptors (PARs) are a family of four receptors where cleavage exposes a new stretch of peptide that then folds back onto the receptor and triggers it. Structural studies have shown that the tethered ligand pushes conserved tyrosine residues downward, causing the transmembrane helix to shift and activate intracellular signaling.25Nature Communications. Structural basis for the activation of proteinase-activated receptors PAR1 and PAR2 Thrombin, a serine protease in the coagulation cascade, is the classic activator of PAR1 on platelets, linking blood clotting to cellular responses. PARs are also involved in inflammation, pain signaling, and tumor biology.
Industrial and Agricultural Uses
Proteases are the most commercially produced enzymes in the world. Subtilisins, a family of bacterial serine proteases, dominate the detergent industry, where they break down protein-based stains. Modern industrial subtilisins are almost entirely engineered variants rather than enzymes harvested directly from natural bacteria, having been optimized through genetic engineering for heat stability, resistance to detergent chemicals and oxidants, and high activity across a range of temperatures.26PubMed Central. Production of subtilisin proteases in bacteria and yeast
Plant-derived proteases have their own niche. Papain from papaya, bromelain from pineapple, ficin from figs, and actinidin from kiwifruit have all been characterized and put to use.27International Dairy Journal. Plant proteases and their application in dairy systems In the food industry, papain is used to tenderize meat, clarify beer, and improve the properties of dairy products. Its ability to hydrolyze a wide range of proteins across varying pH and temperature conditions makes it especially versatile, and treatment with papain can also reduce the allergenicity of certain food proteins.28PubMed. Exploring the extraction, functional properties, and industrial applications of papain from Carica papaya
Proteases in Plant Immunity
Plants lack the adaptive immune system that animals rely on, but they have an elaborate innate defense network in which proteases play central roles. Plant proteases help trigger the hypersensitive response, a localized cell-death reaction that walls off an invading pathogen. They participate in recognizing pathogens, priming defenses in tissues not yet under attack, and releasing peptide hormones that coordinate immune responses across the plant.29PubMed Central. Ten Prominent Host Proteases in Plant-Pathogen Interactions The proteases involved are diverse, belonging to multiple unrelated families and residing at different locations within the cell, which gives the plant multiple independent lines of proteolytic defense.
Convergent Evolution of Protease Active Sites
One of the striking features of protease biology is how often evolution has independently arrived at the same catalytic solution. Serine proteases, for example, have evolved their catalytic triad at least three separate times in unrelated protein folds. The same goes for other catalytic strategies. N-terminal nucleophile hydrolases, a superfamily that includes the proteasome’s own active sites, use their very first amino acid (a serine, threonine, or cysteine freed by autocatalytic processing) as the attacking nucleophile. These enzymes are synthesized as inactive precursors and must clip themselves to become active, an elegant self-activating safety mechanism.30Journal of Biological Chemistry. Divergence and Convergence in Enzyme Evolution This repeated convergence tells us that there are only so many chemical solutions to the problem of breaking peptide bonds in water, and biology has found most of them more than once.
Mapping the Protease Web With Modern Tools
Identifying which proteases cut which substrates in a living cell used to be painstaking work, done one enzyme and one target at a time. Modern mass spectrometry approaches have changed that. Techniques using stable isotope labeling allow researchers to compare protein profiles between cells with and without a particular protease active, revealing dozens of substrates at once. Approaches that specifically capture newly created protein ends (the fresh termini left behind after a protease cuts) make it possible to map cleavage events across an entire proteome.31PubMed. Proteomic discovery of protease substrates Targeted versions of these methods now enable researchers to monitor known cleavage events with high sensitivity in complex biological samples, tracking how protease activity shifts in disease states or in response to drugs.32PubMed. Targeted degradomics in protein terminomics and protease substrate discovery
This broader view has revealed that proteases do not operate in isolation. They form interconnected networks, sometimes called the “protease web,” in which one protease activates or inactivates another, which in turn regulates a third. Understanding these networks is essential for predicting what happens when you inhibit a single protease therapeutically, since blocking one node can have unexpected downstream effects.
Hijacking the Proteasome for New Drugs
A recent and fast-moving area of drug development takes the proteasome’s degradation machinery and redirects it against disease-causing proteins. PROTACs (proteolysis-targeting chimeras) are two-headed molecules: one end grabs the target protein, the other end recruits an E3 ubiquitin ligase, which tags the target for destruction by the proteasome. Unlike a traditional drug that blocks a protein’s active site, a PROTAC eliminates the protein entirely. Molecular glues work on a related principle, modifying the surface of either the target or the ligase so they stick together, again leading to ubiquitination and degradation.33Global Journal of Research in Biology and Pharmacy. PROTACS AND MOLECULAR GLUES: TARGETED PROTEIN DEGRADATION AS A NEXT-GENERATION PHARMACOLOGICAL STRATEGY This approach is particularly exciting for proteins that have historically been considered “undruggable” because they lack a clear pocket for a small molecule to bind. Several PROTACs are now in clinical trials for cancers and other diseases.